chitosan has been researched along with DDPAC in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Lv, X; Tang, C; Yin, C | 1 |
1 other study(ies) available for chitosan and DDPAC
| Article | Year |
|---|---|
Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy.
Topics: Cell Line, Tumor; Chitosan; CRISPR-Cas Systems; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Frontotemporal Dementia; Humans; Nanoparticles; Neoplasms; Plasmids; RNA Interference; Survivin | 2022 |